ALPS
NASDAQ
MY
ALPS Group Inc - Ordinary Share
Healthcare
· Biotechnology
· IPO Oct 2025
$1.01
▲ +$0.00
(+0.00%)
Vol 8K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$144.7M
Beta
0.20
52W
$1–$3
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2023-12-31 | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | — | — | — | — | — |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 8.50 | — | — | — | — | — |
| Current Ratio | 0.05 | 0.05 | 0.01 | 0.25 | 0.25 | 0.25 |
Key Ratios
52W High
$2.90
52W Low
$0.56
$0.56
52-Week Range
$2.90
How does ALPS compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ALPS valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ALPS profitability vs Biotechnology peers
ROE
—
▼
0%
below
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
—
▼
0%
below
peers
(-46.7%)
vs Peers
vs Industry
Top tier
ALPS financial health vs Biotechnology peers
D/E ratio
—
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.3
▼
94%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.2
▼
79%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ALPS fundamentals radar
ALPS
Peer median
Industry
ALPS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ALPS vs peers: key metrics
Latest News
No related news yet